Zusammenfassung
Hintergrund
Für eine individualisierte Therapie und Diagnostik multimorbider, meist älterer und damit geriatrischer Patienten mit Diabetes mellitus ist eine Differenzierung in leicht- und hochgradig eingeschränkte bzw. behinderte sowie palliativ zu behandelnde Patienten hilfreich.
Datenlage
Hintergrund für eine therapeutische und diagnostische Individualisierung sind die Ergebnisse von Langzeittherapiestudien mit protrahierten und lang anhaltenden Effekten einer Blutzuckerspiegeleinstellung sowie die neueren Daten zu den Gefahren schwerer Hypoglykämien.
Therapierisiken
Mit den charakteristischen geriatrischen Syndromen lassen sich die Auswirkungen einer Multimorbidität u. a. auf Multimedikation und die Wechselwirkungen mit einem Diabetes mellitus sehr gut beschreiben. Die frühzeitige Erfassung und Beachtung dieser Defizite kann die Therapierisiken auch in Hinblick auf eine Polypharmazie minimieren helfen.
Abstract
Background
For individualized therapy and diagnosis, differentiation of geriatric patients into mildly and highly disabled patients and palliative patients is helpful.
Data
This differentiation is based on the results of long-term therapeutic trials including extended and long-acting effects of blood glucose control and newer data on the harm of severe hypoglycemia.
Therapy risks
Classification based on characteristic geriatric syndromes is useful to describe the effects of multimorbidity on polypharmacy and interactions with diabetes. Early detection of these deficits can also help minimize the therapeutic risks with respect to polypharmacy.
Literatur
ACCORD Study group (2008) Effects of intensive glucose lowering in type 2 Diabetes. N Engl J Med 358(24):2545–2559
ADA (2015) Standards of medical care 2016. Diabetes Care 38(Suppl1):67–69
Bendayan M et al (2014) Therapeutic interventions for frail elderly patients: part II. Ongoing and unpublished randomized trials. Prog Cardiovasc Dis 57:144–151
Biessels GJ et al (2006) Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 5(1):64–74
Bremer JP et al (2009) Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes. Diabetes Care 32(8):1513–1517
Bruce G et al (2009) Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Freemantle Diabetes Study. Diabetologia 52:1808–1815
DCCT Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986
Duckworth W et al (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360:129–139
Folstein MF et al (1975) „Mini-mental state“: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
Fried LP et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:146–156
Friedman SM et al (2015) Failing to focus on healthy aging: a frailty of our discipline? J Am Geriatr Soc 63:1459–1462
Gerstein HC et al (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545–2559
Hader C et al (2004) Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Alter. Evidenzbasierte Diabetes-Leitlinie DDG. Diabetes Stoffwechs 13:31–56
Holman RR et al (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577–1589
Jackson SL et al (2005) Urinary incontinence and diabetes in Postmeopausal women. Diabetes Care 28:1730–1738
Jaine P et al (2011) The effects of obesity on the pelvic floor. Obstet Gynaecol 13:133–142
Kimbor LB et al (2014) Depression and all-cause mortality in persons with diabetes mellitus: are older adults at higher risk? Results from the translating research into action for diabetes study. J Am Geriatr Soc 62:1017–1022
Kleinridders A et al (2015) Insulin resistance in brain alters dopamine turnover and causes behavioral disorders. Proc Natl Acad Sci USA 112(11):3463–3468
Kopf D, Frölich L (2009) Risk of incident alzheimer’s disease in diabetic patients: a systematic review of prospective trial. J Alzheimers Dis 16:677–685
Landi F et al (2010) Disability, more than multimorbidity, was predictive of mortality among older persons aged 80 years and older. J Clin Epidemiol 63:752–759
Landi F et al (2013) Sarcopenie und Diabetes. J Am Med Dir Assoc 14:540–541
Leenders M et al (2013) Patients with type 2 diabetes show a greater decline in muscle mass, muscle strength, and functional capacity with aging. J Am Med Dir Assoc 14:585–592
Mayne D et al (2010) Diabetes, falls and fractures. Age Ageing 39(5):522–525
Moritz T (2009) Veterans Affairs Diabetes Trial. N Engl J Med 361:1024–1025
Morrison S et al (2010) Balance training reduces falls risk in older individuals with type 2 diabetes. Diabetes Care 33:748–750
Nathan DM et al (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643–2653
Nigel S (2008) Treatment of hypertension in patients 80 years of age or older. N Engl J Med 358:1887–1898
Nikolaus T et al (1995) The time test of money counting. Age Ageing 24:257–258
Nouwen A et al (2010) Type 2 diabetes mellitus as a risk factor fort he onset of depression: a systematic review and meta-analysis. Diabetologia 53(12):2480–2486
Patel A et al (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358:2560–2572
Slavich GM et al (2014) From stress to inflammation and major depressive disorder. Psychol Bull 14(03):774–815
Turner R et al (1996) UK Prospective Diabetes Study 17: a nine year update of a randomized controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med 124:136–145
UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352(9131):837–853
Vetrano DL et al (2014) Association of sarcopenia with short- and long-term mortality in older adults admitted to acute care wards: results from the CRIME study. J Gerontol A Biol Sci Med Sci 69(9):1154–1161
Wernecke J et al (2012) Individuelle Therapieziele bei betagten Diabetespatienten. Diabetologe 8:108–112
Yaffe K et al (2013) Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med 173(14):1300–1306
http://www.dggeriatrie.de. Zugegriffen: 27. Dez. 2016
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
J. Wernecke hat in den letzten 3 Jahren Referentenhonorare erhalten von: Baehr, Böhringer Ingelheim, Chiesi, Lilly, MSD, Novartis, Novo Nordisk.
Dieser Beitrag beinhaltet keine vom Autor durchgeführten Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Wernecke, J. Diabetes mellitus bei multimorbiden Patienten. Diabetologe 13, 79–84 (2017). https://doi.org/10.1007/s11428-016-0180-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11428-016-0180-8